RJA
DRIO icon

Raymond James & Associates’s DarioHealth DRIO Stock Holding History

Raymond James & Associates’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,248
Closed -$533K – 4157
2021
Q2 		$533K Buy
1,248
+10
+0.8% +$3.81K ﹤0.01% 3035
2021
Q1 		$477K Buy
+1,238
New +$558K ﹤0.01% 3060

Other funds holding DRIO

CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's DRIO Position: Q3 2021 in Review

Raymond James & Associates sold out of DarioHealth (DRIO) in Q3 2021, closing a stake of 1,248 shares — an estimated $533K sold.

Raymond James & Associates first reported a position in DRIO in Q1 2021 and held it in 2 quarters. The position peaked at $533K in Q2 2021. 57 funds tracked by Wall St. Rank hold DRIO as of Q3 2021.

  • Raymond James & Associates reported no remaining DarioHealth position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 1,248 DarioHealth shares in Q3 2021, an estimated $533K.
  • Raymond James & Associates first reported a position in DarioHealth in Q1 2021 and held it in 2 quarters.
  • Raymond James & Associates's DarioHealth position peaked at $533K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held DarioHealth as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.